Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Extra-intestinal manifestations of IBD

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Recognise inflammatory, thrombotic, hepatobiliary, nutritional and treatment-related disease beyond the bowel, identify emergencies, and coordinate therapy that respects both intestinal and organ-specific needs.

  • Extra-intestinal manifestations can involve joints, eyes, skin, liver, blood, bone, kidneys, lungs and nervous system, and some appear before IBD is diagnosed.
  • Peripheral arthritis associated with active colitis may improve when bowel inflammation is controlled, whereas axial spondyloarthritis often follows an independent course and needs rheumatology care.
  • A painful photophobic red eye or reduced vision is uveitis until urgently assessed; simple episcleritis is usually less painful and does not impair vision.
  • Erythema nodosum usually presents as tender shin nodules and often tracks bowel activity; pyoderma gangrenosum causes rapidly progressive painful ulceration and can worsen after trauma.
  • Persistent cholestatic liver tests require assessment for primary sclerosing cholangitis and other hepatic causes; PSC changes colorectal and biliary cancer surveillance.
  • Active IBD, hospitalisation and surgery increase venous-thromboembolism risk, so formal prophylaxis assessment is essential even when non-major rectal bleeding is present.
  • Anaemia, osteoporosis, gallstones and renal stones may reflect inflammation, malabsorption, ileal disease, resection or corticosteroid exposure rather than a separate coincidence.
  • Before calling a new syndrome extra-intestinal IBD, exclude infection, medicine toxicity and unrelated disease because immunosuppression can make these presentations atypical.

Key red flags

A painful photophobic red eye, reduced vision or abnormal pupil needs same-day ophthalmology assessment to prevent irreversible visual damage.

A hot swollen single joint with fever is septic arthritis until excluded and must not be treated as routine IBD arthropathy with more immunosuppression.

Rapidly progressive painful skin ulceration should prompt dermatology review before surgical debridement because pyoderma gangrenosum can worsen through pathergy.

Jaundice with fever, right upper-quadrant pain, hypotension or confusion suggests acute cholangitis and requires urgent sepsis, biliary and hepatology management.

New dyspnoea, pleuritic pain, unilateral swelling, focal neurology or severe headache requires emergency thrombosis assessment.

Focal spinal pain, height loss or fracture after corticosteroid exposure needs urgent structural and bone review, not analgesia alone.

Investigation priorities

01
Objective IBD activity assessmentFirst step

Determine whether the extra-intestinal syndrome tracks uncontrolled bowel inflammation.

Management branches

TRIAGEIdentify the threatened organ

A patient with known or suspected IBD presents with a new joint, eye, skin, liver, neurological or cardiorespiratory syndrome.

  1. Assess vision, sepsis, joint destruction, thrombosis, biliary obstruction and neurological function first, using emergency specialist pathways when an organ is threatened.
  2. Relate onset to bowel symptoms, objective IBD activity, recent infection, immunosuppression, corticosteroid changes and newly introduced medicines.
  3. Obtain targeted examination and investigations rather than labelling the syndrome from association alone, actively excluding infection and drug toxicity.
  4. Contact the relevant specialty and IBD team early so one treatment plan does not worsen the other disease domain.

Key medicines

Topical ocular corticosteroidOphthalmologist-directed preparation, frequency and taper after slit-lamp diagnosis of uveitis.Do not initiate prolonged treatment without eye assessment; infection, glaucoma, cataract and posterior disease require specialist monitoring and sometimes systemic therapy.
Monoclonal anti-TNF therapyLicensed specialist induction and maintenance regimen chosen for both IBD and extra-intestinal phenotype.Drain infection first and screen tuberculosis and hepatitis; not every anti-TNF formulation has equivalent evidence across manifestations, and paradoxical psoriasis can occur.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BSG Inflammatory bowel disease guideline 2025Current UK extra-intestinal manifestation assessment and therapy.
  • NICE NG65 Spondyloarthritis recommendationsRecognition, imaging and multidisciplinary management of axial and peripheral disease.
  • BSG Primary sclerosing cholangitis guidelineBritish diagnostic, biliary and surveillance principles for PSC.
  • NICE NG89 Venous thromboembolism preventionHospital thrombosis risk assessment and prophylaxis safeguards.
  • NICE TA460 Non-infectious uveitis treatmentsSpecialist treatment options for selected sight-threatening non-infectious uveitis.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom